Browse by Phase
Phase 2 / Phase 3 Clinical Trials
Phase 2/3 combined trials bridge efficacy assessment and large-scale comparison, enrolling larger cohorts while still gathering dose-response data.
Total Trials
104
Recruiting Now
104
Top Conditions in Phase 2 / Phase 3
NCT06969729 Phase 2, Phase 3
Recruiting
Evaluation of Clinical Efficacy and Safety of Aortal Stent-Graft Created Using 3...
Condition
Abdominal Aortic Aneurysm
Enrollment
100 pts
Location
Poland
Sponsor
Samodzielny Publiczny Szpital
NCT06900881 Phase 2, Phase 3
Recruiting
Role of Kefir Mouth Wash in Oral Health Status Amelioration
Condition
Plaque Induced Gingivitis
Enrollment
60 pts
Location
Iraq
Sponsor
Al-Mustansiriyah University
NCT06572553 Phase 2, Phase 3
Recruiting
Evaluation of Therapeutic Efficacy of Faricimab for Clinical AMD, DME, and RVO P...
Condition
Age-Related Macular Degeneration
Enrollment
30 pts
Location
China
Sponsor
Second Affiliated Hospital, Sc
NCT07047339 Phase 2, Phase 3
Recruiting
Evaluate the Efficacy and Safety of Probiotic 6600 as an Adjuvant Therapy for Co...
Condition
Colitis
Enrollment
120 pts
Location
China
Sponsor
Changhai Hospital
NCT04549610 Phase 2, Phase 3
Recruiting
HMB and Exercise-induced Muscle Damage
Condition
Supplementation
Enrollment
30 pts
Location
Brazil
Sponsor
Poznan University of Physical
NCT07298642 Phase 2, Phase 3
Recruiting
Extended-field Proton Therapy for Cervical Cancer
Condition
Cervical Cancer
Enrollment
44 pts
Location
Taiwan
Sponsor
National Taiwan University Hos
NCT07459790 Phase 2, Phase 3
Recruiting
The Study is Being Conducted to Find a New Treatment for Patients Suffering From...
Condition
IC
Enrollment
180 pts
Location
Russia
Sponsor
JSC NextGen
NCT04147286 Phase 2, Phase 3
Recruiting
Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion
Condition
Tuberculosis, Pulmonary
Enrollment
220 pts
Location
South Africa
Sponsor
University of Cape Town
NCT06316830 Phase 2, Phase 3
Recruiting
Identifying Optimal Buprenorphine Dosing for Opioid Use Disorder Treatment and P...
Condition
Opioid Use Disorder
Enrollment
250 pts
Location
United States
Sponsor
Rhode Island Hospital
NCT05587036 Phase 2, Phase 3
Recruiting
Effects of Rifaximin on Gut Microbiota and Emotion
Condition
Healthy Volunteers
Enrollment
60 pts
Location
Belgium
Sponsor
Universitaire Ziekenhuizen KU
NCT06879379 Phase 2, Phase 3
Recruiting
KPD Consolidation After ASCT in NDMM Patients
Condition
Multiple Myeloma, Newly Diagnosed
Enrollment
202 pts
Location
China
Sponsor
Peking University People's Hos
NCT06988475 Phase 2, Phase 3
Recruiting
DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harb...
Condition
Solid Tumour
Enrollment
30 pts
Location
United Kingdom
Sponsor
Cancer Research UK
NCT05491525 Phase 2, Phase 3
Recruiting
A Study of Vibegron in Pediatric Participants 2 Years to Less Than (<) 18 Years ...
Condition
Neurogenic Detrusor Overactivity
Enrollment
85 pts
Location
United States
Sponsor
Urovant Sciences GmbH
NCT04302870 Phase 2, Phase 3
Recruiting
Motor Neurone Disease - Systematic Multi-Arm Adaptive Randomised Trial
Condition
Motor Neuron Disease, Amyotrophic Lateral Sclerosis
Enrollment
1,150 pts
Location
United Kingdom
Sponsor
University of Edinburgh
NCT07229651 Phase 2, Phase 3
Recruiting
Metformin in Parkinson Disease
Condition
Parkinson Disease
Enrollment
60 pts
Location
Egypt
Sponsor
Tanta University
NCT07323329 Phase 2, Phase 3
Recruiting
Growth Hormone and Dehydroepiandrosterone Role in Vitro Fertilization
Condition
Infertility
Enrollment
165 pts
Location
Egypt
Sponsor
Beni-Suef University
NCT07287644 Phase 2, Phase 3
Recruiting
A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa
Condition
Hidradenitis Suppurativa (HS)
Enrollment
210 pts
Location
United States
Sponsor
Bluefin Biomedicine, Inc.
NCT06193889 Phase 2, Phase 3
Recruiting
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patien...
Condition
Myasthenia Gravis
Enrollment
66 pts
Location
United States, Brazil, Germany
Sponsor
Kyverna Therapeutics
NCT06061848 Phase 2, Phase 3
Recruiting
Intralymphatic Immunotherapy Enhanced by Vitamin-D, a Randomized Placebo-control...
Condition
Allergic Rhinitis Due to Grass Pollen
Enrollment
360 pts
Location
Sweden
Sponsor
Lars Olaf Cardell
NCT04973306 Phase 2, Phase 3
Recruiting
Neoadjuvant Immunotherapy Plus CRT Versus Neoadjuvant CRT for Locally Advanced R...
Condition
Esophageal Squamous Cell Carcinoma Stage II
Enrollment
176 pts
Location
China
Sponsor
Shanghai Zhongshan Hospital
NCT07084662 Phase 2, Phase 3
Recruiting
Xinlikang Capsule for Chemotherapy-induced Fatigue and Immune Disorders in Diffu...
Condition
Diffuse Large B-Cell Lymphoma (DLBCL)
Enrollment
80 pts
Location
China
Sponsor
Sun Yat-sen University
NCT06843668 Phase 2, Phase 3
Recruiting
Different Dosing Strategies of Colistin in Multidrug-Resistant Gram-Negative Bac...
Condition
Critical Ill Patients
Enrollment
120 pts
Location
Saudi Arabia
Sponsor
Mansoura University
NCT05786768 Phase 2, Phase 3
Recruiting
Efficacy and Safety of Obinutuzumab Versus Rituximab in Childhood Steroid Depend...
Condition
Steroid-Dependent Nephrotic Syndrome
Enrollment
88 pts
Location
France
Sponsor
Assistance Publique - Hôpitaux
NCT06715449 Phase 2, Phase 3
Recruiting
EMPA-ESUS. a Randomised Control Trial to Investigate the Impact of Empagliflozin...
Condition
Embolic Stroke of Undetermined Source
Enrollment
100 pts
Location
United Kingdom
Sponsor
University of East Anglia
NCT02707497 Phase 2, Phase 3
Recruiting
The Effect of REcombinant Human Thrombopoietin (rhTPO) on Sepsis Patients With a...
Condition
Sepsis
Enrollment
200 pts
Location
China
Sponsor
Ruilan Wang